1. Le Manach C, Cabrera DG, Douelle F, Nchinda AT, Younis Y, Taylor D, Wiesner L, White KL, Ryan E, March C, Duffy S, Avery VM, Waterson D, Witty MJ, Wittlin S, Charman SA, Street LJ, Chibale K (2014) J Med Chem 57:2789
2. Enguehard-Gueiffier C, Musiu S, Henry N, Veron JB, Mavel S, Neyts J, Leyssen P, Paeshuyse J, Gueiffier A (2013) Eur J Med Chem 64:448
3. Berdini V, Besong GE, Callaghan O, Carr MG, Congreve MS, Gill AL, Griffiths-Jones CM, Madin A, Murray CW, Nijjar RK, O’Brien MA, Pike A, Saxty G, Taylor RD, Vickerstaffe E (2013) Imidazo[1,2-a]pyridine compounds for use in treating cancer. US Patent 8,513,276, Aug 20, 2013; (2008) Chem Abstr 149:128826
4. Koppitz M, Klar U, Jautelat R, Kosemund D, Bohlmann R, Bader B, Lienau P, Siemeister G (2014) 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders. US Patent 2014/0187548, Jul 3, 2014; (2012) Chem Abstr 157:104707
5. Ince S, Haegebarth A, Politz O, Neuhaus R, Bömer U, Scott W (2012) Substituted imidazo[1,2-a]pyrimidines and -pyridines. WO Patent 2012/007345, Jan 19, 2012; (2012) Chem Abstr 156:203296